Page last updated: 2024-08-21

adamantane and Grippe

adamantane has been researched along with Grippe in 104 studies

Research

Studies (104)

Timeframe	Studies, this research(%)	All Research%
pre-1990	36 (34.62)	18.7374
1990's	2 (1.92)	18.2507
2000's	34 (32.69)	29.6817
2010's	28 (26.92)	24.3611
2020's	4 (3.85)	2.80

Authors

Authors	Studies
Caffrey, M; Degrado, WF; Kolocouris, A; Konstantinidi, A; Lambrinidis, G; Liu, L; Tan, J; Thomaston, JL; Wang, J	1
Deryabin, PG; Finogenova, MP; Garaev, TM; Odnovorov, AI	1
Duncan, MC; Fedida, D; Jalily, PH; Tietjen, I; Wang, J	1
DeGrado, WF; Voth, GA; Watkins, LC	1
Dong, G; He, W; Wang, C; Wu, Q; Xie, Y; Xu, H; Yan, H; Zhang, W	1
Barr, I; Deng, YM; Hurt, A; Kaye, M; Komadina, N; Subbarao, K; Sullivan, S	1
Acosta, B; Arencibia, A; González, G; Goyenechea, A; Hernández, B; Muné, M; Oropesa, S; Pérez, A; Piñón, A; Savón, C; Valdés, O	1
Aris-Brosou, S; Garcia, V	1
Chun, K; Lessler, J; Rainwater-Lovett, K	1
Hurt, AC	1
Dong, G; Han, L; He, H; Ji, G; Luo, J; Peng, C; Wang, C; Wu, B	1
Beggs, NF; Dobrovolny, HM	1
Korabecny, J; Kuca, K; Nepovimova, E; Soukup, O; Spilovska, K; Windisch, M; Zemek, F	1
DeGrado, WF; Hu, Y; Ma, C; Musharrafieh, R; Smee, DF; Wang, J; Zhang, J	1
Barr, IG; Deng, YM; Hurt, AC; Iannello, P; Komadina, N	1
Cohen, NJ; Gerber, SI; Jones, RC; Morita, JY; Nawrocki, J; Plate, DK; Simon, MT; Siston, AM	1
Guralnick, RP; Habib, F; Hill, AW; Janies, D; Wilson, MJ	1
Cristina, J; Goñi, N; Russi, J	1
Laplante, JM; Marshall, SA; Mingle, LA; Reisdorf, ES; Shudt, M; Shult, PA; St George, K; Van, TT	1
Jacobson, RM; Ovsyannikova, IG; Poland, GA	1
Holmes, EC; Miller, MA; Nelson, MI; Simonsen, L; Viboud, C	1
Huang, LM; Shao, PL	1
Cilla, G; Mendiola, J; Montes, M; Pérez-Trallero, E; Vicente, D	1
Hannongbua, S; Intharathep, P; Kaiyawet, N; Malaisree, M; Nunthaboot, N; Payungporn, S; Poovorawan, Y; Rungrotmongkol, T; Sompornpisut, P	1
Agudo, R; Barrantes, M; Comach, G; de Rivera, I; Douce, R; García, J; Gomez, J; Jimenez, M; Kochel, T; Sanchez, F; Sovero, M; Torres, AL	1
Raguram, S; Raman, R; Sasisekharan, R; Sasisekharan, V; Shriver, Z; Soundararajan, V; Tharakaraman, K	1
Dijkstra, F; Jonges, M; Koopmans, M; Meijer, A; van der Lubben, IM; Verhoef, L	1
Barnes, J; Deyde, V; Garten, R; Gubareva, L; Klimov, A; Myrick, A; Shaw, M; Sheu, T; Smith, C; Xu, X	1
Abughali, N; Abzug, MJ; Bradley, JS; Cloud, GA; Englund, J; Griffin, J; Guzman-Cottrill, J; Jacobs, RF; Jester, P; Kimberlin, DW; Lang, D; Leach, C; Ramilo, O; Robinson, J; Romero, JR; Shalabi, M; Shelton, M; Storch, G; Wade, KC; Whitley, RJ	1
Chen, KF; Gaydos, CA; Hsieh, YH; Kelen, GD; Rothman, RE	1
Antón, A; de Anta, MT; de Molina, P; Isanta, R; Marcos, MA; Martínez, MJ; Pumarola, T; Ramón, S	1
Barontini, M; Crucianelli, M; Nencioni, L; Palamara, AT; Saladino, R; Sgarbanti, R	1
Arkin, IT; Astrahan, P	1
Beekmann, SE; Dharan, NJ; Finelli, L; Fiore, A; Fry, AM; Polgreen, PM; Uyeki, TM	1
Gums, JG; Smith, SM	1
Basler, CF; Fytas, C; Fytas, G; Kolocouris, A; Valmas, C; Zoidis, G	1
Ison, MG; Lee, N	1
de Jong, MD; Hayden, FG	1
Bullion, L; Deyde, VM; Fry, AM; Garten, RJ; Gubareva, LV; Klimov, AI; Li, Y; Peebles, PJ; Sheu, TG; Shwe, T	1
Deyde, VM; Fry, AM; Garten, RJ; Gubareva, LV; Klimov, AI; Mishin, VP; Nguyen, HT; Okomo-Adhiambo, M; Shaw, MW; Sheu, TG; Sleeman, K; Trujillo, AA	1
Alcantara-Perez, P; Alpuche-Aranda, C; Barrera-Badillo, G; Cordova Villalobos, JA; Cortez-Ortiz, I; Díaz-Quiñonez, JA; Gatell-Ramírez, HL; Gonzalez-Duran, E; Gubareva, L; Hernández-Avila, M; Lezana-Fernández, MA; Lopez-Martinez, I; Nguyen, H; Olivera-Diaz, H; Ramirez-Gonzalez, JE; Wong-Arambula, C	1
Hou, N; Jonges, M; Ke, C; Koopmans, M; Li, H; Liao, J; Meijer, A; Ni, H; Wang, Y; Wu, J; Zhang, X; Zhou, J; Zou, L	1
Rohde, GG	1
Bonovas, S; Nikolopoulos, G; Tsiodras, S	1
Boucher, CA; Collins, PJ; Gamblin, SJ; Haire, LF; Hay, AJ; Liu, J; Martin, SR; Osterhaus, AD; Schutten, M; Skehel, JJ; Vachieri, SG; van der Vries, E; Walker, PA; Xiong, X	1
De Clercq, E; Foscolos, GB; Fytas, G; Kolocouris, A; Kolocouris, N; Neyts, J; Padalko, E; Stylianakis, I	1
Lu, Q	1
Moscona, A	1
Chen, H; Guan, Y	1
Bright, RA; Cox, NJ; Klimov, AI; Shay, DK; Shu, B	1
Weinstock, DM; Zuccotti, G	1
Linder, JA	1
Barr, IG; Deed, N; Hurt, AC; Iannello, P; Komadina, N; Tomasov, C	2
Shah, RC	1
Shea, KM	1
Amicizia, D; Ansaldi, F; Banfi, F; Crovari, P; Gasparini, R; Icardi, G; Pastorino, B; Sticchi, L; Valle, L	1
Barr, I; Ho, HT; Hurt, AC	1
Dushoff, J; Gog, J; Grenfell, BT; Hata, M; Holmes, EC; Jennings, L; Macken, C; Miller, MA; Simonsen, L; Smit, M; Viboud, C	1
Campbell, JD	1
Balish, A; Belongia, EA; Bright, RA; Cox, NJ; Donahue, JG; Foust, A; Greenlee, RT; Kieke, BA; Klimov, AI; Rahman, M; Shay, DK; Vandermause, M	1
Fonseca, K; Fox, JD; Ho, KC; Pabbaraju, K; Pang, XL; Shokoples, S; Wong, S	1
Chan, PK; Lam, WY; Ngai, KL; Tang, JW; Wong, JC	1
Efremov, BV; Erofeeva, MK; Ignat'eva, GS; Maksakova, VL; Malysheva, AM	1
Araslanova, II; Gagarinova, VM; Kubar', OI; Kustikova, IuG; Shadrin, AS	1
Bigimbetova, ShSh; Smagulov, KZ; Smagulova, EG	1
Gorenskaia, RL; Kubar', OI; Leonov, VM; Romanov, IuA; Rumel', NB	1
Gorenskaia, RA; Kubar', OI; Padalko, IuV; Reĭkh, LIa; Romanov, IuA	1
Kubar', OI; Romanov, IuA; Rumen', NB; Vasilevskaia, NM; Zherbina, LA	1
Bregman, DJ; Kater, NA; Kendal, AP; Patriarca, PA; Sikes, RK; Smith, JD	1
Erofeeva, MK; Shadrin, AS	1
Sebastiani, A	1
Dolin, R; Linton, PN; Madore, HP; Maynard, R; Reichman, RC; Webber-Jones, J	1
Hayden, FG; Iljenko, VI; Padolka, YV; Zylidnikov, DM	1
Erofeeva, MK; Lugovskaia, VP; Malysheva, AM; Oleĭnikova, EV; Shadrin, AS	1
Geĭker, VI; Romanov, IuA; Rumel', NB; Vasilevskaia, NM; Zlydnikov, DM	1
Zlydnikov, DM	3
Cate, TR; Couch, RB; Goswick, CB; Quarles, JM	1
Hayden, FG; Kaiser, L	1
Krylov, VF	1
Eggers, HJ	1
Galasso, GJ; LaMontagne, JR	1
Alekseeva, AA; Demidova, SA; Krylov, VF; Kuptsevich, TP; Smagulova, EG	1
Oxford, JS	1
Arroyo, M; Beare, AS; Craig, JW; Reed, SE	1
Boissel, JP; Bricaire, F; Hannoun, C	1
Belshe, RB; Clover, RD; Hay, AJ; Hayden, FG; Oakes, MG; Soo, W	1
Betts, RF	1
Bentley, DW; Betts, RF; Karki, SD	1
Belshe, RB; Burk, B; Cerruti, RL; Newman, F; Sim, IS	1
Kubar', OI; Shvetsova, EG; Zlydnikov, DM	1
Belshe, RB; Betts, R; Hall, CB; Hay, AJ; Smith, MH	1
Abell, TD; Clover, RD; Couch, RB; Crawford, SA; Glezen, P; Ramsey, CN	1
Disney, FA; Dolin, R; Francis, AB; Gala, CL; Green, JL; Hall, CB; Madore, PH; Markovitz, DM; Talpey, WB; Zhang, YQ	1
Hayden, FG; Tominack, RL	1
Abell, TD; Clover, RD; Couch, RB; Crawford, SA; Glezen, WP; Ramsey, CN	1
Hayden, FG; Monto, AS	1
Fleet, W; Lawrence, E; Morris, L; Pierce, E; Thompson, J; Wright, P	1

Reviews

16 review(s) available for adamantane and Grippe

Article	Year
Put a cork in it: Plugging the M2 viral ion channel to sink influenza. Antiviral research, 2020, Volume: 178 Topics: Adamantane; Animals; Antiviral Agents; Drug Development; Drug Discovery; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Ion Channels; Orthomyxoviridae Infections; Viral Matrix Proteins; Virus Replication	2020
Influenza outbreak control practices and the effectiveness of interventions in long-term care facilities: a systematic review. Influenza and other respiratory viruses, 2014, Volume: 8, Issue:1 Topics: Adamantane; Aged; Antiviral Agents; Chemoprevention; Disease Outbreaks; Health Facilities; Humans; Infection Control; Influenza, Human; Long-Term Care; Masks	2014
The epidemiology and spread of drug resistant human influenza viruses. Current opinion in virology, 2014, Volume: 8 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation, Missense; Neuraminidase; Oseltamivir; Viral Proteins; Virulence	2014
Adamantane - A Lead Structure for Drugs in Clinical Practice. Current medicinal chemistry, 2016, Volume: 23, Issue:29 Topics: Adamantane; Alzheimer Disease; Antiviral Agents; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Influenza, Human	2016
Current advances in anti-influenza therapy. Current medicinal chemistry, 2010, Volume: 17, Issue:20 Topics: Adamantane; Antiviral Agents; Cyclohexenes; Cyclopentanes; Flavonoids; Glutathione; Heterocyclic Compounds; Humans; Influenza, Human; Orthomyxoviridae; Phenols; Polyphenols	2010
Resistance characteristics of influenza to amino-adamantyls. Biochimica et biophysica acta, 2011, Volume: 1808, Issue:2 Topics: Adamantane; Amantadine; Amino Acid Sequence; Drug Resistance, Viral; Genes, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Ion Channels; Models, Molecular; Molecular Sequence Data; Mutation; Protein Stability; Protein Structure, Tertiary; Rimantadine; Sequence Homology, Amino Acid; Viral Matrix Proteins	2011
Antivirals for influenza: strategies for use in pediatrics. Paediatric drugs, 2010, Oct-01, Volume: 12, Issue:5 Topics: Adamantane; Animals; Antiviral Agents; Child; Drug Therapy, Combination; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae; Pediatrics	2010
Influenza 2010-2011: lessons from the 2009 pandemic. Cleveland Clinic journal of medicine, 2010, Volume: 77, Issue:11 Topics: Adamantane; Antiviral Agents; Diagnostic Tests, Routine; Disease Outbreaks; Drug Resistance; Global Health; Humans; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Risk Factors; Seasons	2010
Antivirals used for influenza chemoprophylaxis. Current medicinal chemistry, 2012, Volume: 19, Issue:35 Topics: Adamantane; Antiviral Agents; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase; Orthomyxoviridae	2012
Neuraminidase inhibitors for influenza. The New England journal of medicine, 2005, Sep-29, Volume: 353, Issue:13 Topics: Acetamides; Adamantane; Adult; Aged; Antiviral Agents; Child; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Oseltamivir; Pyrans; Sialic Acids; Zanamivir	2005
Resistance to anti-influenza drugs: adamantanes and neuraminidase inhibitors. Expert review of anti-infective therapy, 2006, Volume: 4, Issue:5 Topics: Adamantane; Animals; Antiviral Agents; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase	2006
Antiviral therapy and prophylaxis for influenza in children. Pediatrics, 2007, Volume: 119, Issue:4 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Infant; Influenza, Human; Male; Oseltamivir; Primary Prevention; Prospective Studies; Randomized Controlled Trials as Topic; Rimantadine; Risk Assessment; Severity of Illness Index; Treatment Outcome; Zanamivir	2007
Hospitalizing influenza in adults. Current clinical topics in infectious diseases, 1999, Volume: 19 Topics: Adamantane; Adult; Antiviral Agents; Enzyme Inhibitors; Female; Hospitalization; Humans; Immunocompromised Host; Influenza, Human; Male; Neuraminidase; Pneumonia, Viral	1999
Specific inhibitors of influenza virus replication as potential chemoprophylactic agents. The Journal of antimicrobial chemotherapy, 1975, Volume: 1, Issue:1 Topics: Adamantane; Amantadine; Animals; Antiviral Agents; DNA-Directed RNA Polymerases; Drug Resistance, Microbial; Humans; Influenza, Human; Models, Molecular; Orthomyxoviridae; Ribavirin; Virus Replication	1975
Amantadine and rimantadine for the prevention of influenza A. Seminars in respiratory infections, 1989, Volume: 4, Issue:4 Topics: Adamantane; Adult; Age Factors; Aged; Amantadine; Child; Humans; Influenza A virus; Influenza, Human; Rimantadine; Seasons; United States	1989
Rimantadine hydrochloride and amantadine hydrochloride use in influenza A virus infections. Infectious disease clinics of North America, 1987, Volume: 1, Issue:2 Topics: Adamantane; Adult; Aged; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine	1987

Trials

15 trial(s) available for adamantane and Grippe

Article	Year
[Evaluation of rimantadine effectiveness during influenza A2-Texas epidemic in 1979-1980]. Klinicheskaia meditsina, 1981, Volume: 59, Issue:2 Topics: Adamantane; Clinical Trials as Topic; Disease Outbreaks; Dose-Response Relationship, Drug; Drug Administration Schedule; Humans; Influenza A virus; Influenza, Human; Rimantadine; Russia	1981
Safety of prolonged administration of rimantadine hydrochloride in the prophylaxis of influenza A virus infections in nursing homes. Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:1 Topics: Adamantane; Cross Infection; Humans; Influenza A virus; Influenza, Human; Nursing Homes; Rimantadine; Time Factors	1984
A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. The New England journal of medicine, 1982, Sep-02, Volume: 307, Issue:10 Topics: Adamantane; Adolescent; Adult; Amantadine; Clinical Trials as Topic; Humans; Infant, Newborn; Influenza A virus; Influenza, Human; Middle Aged; Patient Compliance; Random Allocation; Rimantadine	1982
Comparative therapeutic effect of aerosolized and oral rimantadine HCl in experimental human influenza A virus infection. Antiviral research, 1982, Volume: 2, Issue:3 Topics: Adamantane; Administration, Oral; Aerosols; Female; Fever; Humans; Influenza, Human; Male; Rimantadine	1982
From the National Institutes of Health. Report of a workshop on clinical studies of the efficacy of amantadine and rimantadine against influenza vireus. The Journal of infectious diseases, 1978, Volume: 138, Issue:6 Topics: Adamantane; Amantadine; Bridged-Ring Compounds; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Humans; In Vitro Techniques; Influenza, Human; Michigan; National Institutes of Health (U.S.); Orthomyxoviridae; Placebos; United States	1978
[Use of rimantadine for the treatment and prevention of influenza in the polyclinic]. Sovetskaia meditsina, 1979, Issue:5 Topics: Adamantane; Bridged-Ring Compounds; Clinical Trials as Topic; Drug Evaluation; Humans; Influenza, Human; Moscow; Time Factors	1979
A therapeutic study of an adamantane spiro compound in experimental influenza A infection in man. The Journal of antimicrobial chemotherapy, 1975, Volume: 1, Issue:4 Suppl Topics: Adamantane; Adolescent; Adult; Bridged-Ring Compounds; Clinical Trials as Topic; Female; Humans; Influenza A virus; Influenza, Human; Male; Middle Aged; Placebos; Spiro Compounds; Time Factors	1975
[Prevention of influenza A. Effectiveness and tolerance of rimantadine hydrochloride]. Presse medicale (Paris, France : 1983), 1990, Jan-20, Volume: 19, Issue:2 Topics: Adamantane; Clinical Trials as Topic; Drug Evaluation; Female; France; Humans; Influenza A virus; Influenza, Human; Male; Placebos; Premedication; Rimantadine	1990
Emergence and apparent transmission of rimantadine-resistant influenza A virus in families. The New England journal of medicine, 1989, Dec-21, Volume: 321, Issue:25 Topics: Adamantane; Administration, Oral; Adolescent; Adult; Aged; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Resistance, Microbial; Female; Humans; Infant; Influenza A virus; Influenza, Human; Male; Middle Aged; Random Allocation; Rimantadine	1989
Genetic basis of resistance to rimantadine emerging during treatment of influenza virus infection. Journal of virology, 1988, Volume: 62, Issue:5 Topics: Adamantane; Amino Acid Sequence; Base Sequence; Clinical Trials as Topic; Drug Resistance, Microbial; Humans; Influenza A virus; Influenza, Human; Molecular Sequence Data; Rimantadine	1988
Rimantadine prophylaxis in children: a follow-up study. The Pediatric infectious disease journal, 1988, Volume: 7, Issue:6 Topics: Adamantane; Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Drug Tolerance; Follow-Up Studies; Humans; Infant; Influenza, Human; Lung Diseases, Obstructive; Rimantadine; Risk Factors	1988
Children with influenza A infection: treatment with rimantadine. Pediatrics, 1987, Volume: 80, Issue:2 Topics: Acetaminophen; Adamantane; Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infant; Influenza, Human; Male; Random Allocation; Rimantadine	1987
Effectiveness of rimantadine prophylaxis of children within families. American journal of diseases of children (1960), 1986, Volume: 140, Issue:7 Topics: Adamantane; Adolescent; Adult; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infant; Influenza A virus; Influenza B virus; Influenza, Human; Male; Office Visits; Patient Compliance; Random Allocation; Rimantadine	1986
Oral rimantadine hydrochloride therapy of influenza A virus H3N2 subtype infection in adults. Antimicrobial agents and chemotherapy, 1986, Volume: 29, Issue:2 Topics: Adamantane; Administration, Oral; Adult; Body Temperature; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Influenza A virus; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Nasal Mucosa; Random Allocation; Rimantadine	1986
A comparison of acetaminophen and rimantadine in the treatment of influenza A infection in children. Journal of medical virology, 1987, Volume: 21, Issue:3 Topics: Acetaminophen; Adamantane; Child; Child, Preschool; Clinical Trials as Topic; Double-Blind Method; Humans; Infant; Influenza A virus; Influenza, Human; Random Allocation; Rimantadine	1987

Other Studies

73 other study(ies) available for adamantane and Grippe

Article	Year
X-ray Crystal Structures of the Influenza M2 Proton Channel Drug-Resistant V27A Mutant Bound to a Spiro-Adamantyl Amine Inhibitor Reveal the Mechanism of Adamantane Resistance. Biochemistry, 2020, 02-04, Volume: 59, Issue:4 Topics: Adamantane; Amines; Antiviral Agents; Binding Sites; Crystallography, X-Ray; Drug Resistance, Bacterial; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Ligands; Molecular Dynamics Simulation; Mutation; Radiography; Viral Matrix Proteins	2020
[Assessment of the antiviral activity of 2HClH-His-Rim compound compared to the anti-influenza drug Arbidol for influenza caused by A/duck/Novosibirsk/56/05 (H5N1) (Influenza A virus, Alphainfluenzavirus, Orthomyxoviridae).] Voprosy virusologii, 2019, Volume: 64, Issue:6* Topics: Adamantane; Animals; Antiviral Agents; Chlorocebus aethiops; Drug Resistance, Viral; Ducks; Humans; Indoles; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza, Human; Microbial Sensitivity Tests; Vero Cells; Viral Load; Virus Replication	2019
Influenza A M2 Inhibitor Binding Understood through Mechanisms of Excess Proton Stabilization and Channel Dynamics. Journal of the American Chemical Society, 2020, 10-14, Volume: 142, Issue:41 Topics: Adamantane; Amino Acid Sequence; Antiviral Agents; Binding Sites; Drug Design; Humans; Influenza A virus; Influenza, Human; Molecular Dynamics Simulation; Protein Binding; Protein Conformation; Protons; Viral Matrix Proteins	2020
Distribution and evolution of H1N1 influenza A viruses with adamantanes-resistant mutations worldwide from 1918 to 2019. Journal of medical virology, 2021, Volume: 93, Issue:6 Topics: Adamantane; Animals; Antiviral Agents; Drug Resistance, Viral; Europe; Evolution, Molecular; Host Specificity; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; North America; Orthomyxoviridae Infections; Phylogeny; Swine; Viral Proteins	2021
Detection of adamantane-sensitive influenza A(H3N2) viruses in Australia, 2017: a cause for hope? Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2017, Volume: 22, Issue:47 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Australia; Drug Resistance, Viral; Genome, Viral; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Phylogeny; RNA, Viral; Seasons; Sequence Analysis, DNA	2017
Adamantane and neuraminidase inhibitor resistance among circulating human influenza A viruses in Cuba during 2006-2010. International journal of antimicrobial agents, 2013, Volume: 42, Issue:1 Topics: Adamantane; Antiviral Agents; Cuba; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Molecular Sequence Data; Mutation, Missense; Neuraminidase; RNA, Viral; Sequence Analysis, DNA	2013
Comparative dynamics and distribution of influenza drug resistance acquisition to protein m2 and neuraminidase inhibitors. Molecular biology and evolution, 2014, Volume: 31, Issue:2 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Genome, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; United States; United States Food and Drug Administration; Viral Matrix Proteins	2014
Adamantane-resistant influenza a viruses in the world (1902-2013): frequency and distribution of M2 gene mutations. PloS one, 2015, Volume: 10, Issue:3 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Mutation; Viral Matrix Proteins	2015
Determining drug efficacy parameters for mathematical models of influenza. Journal of biological dynamics, 2015, Volume: 9 Suppl 1 Topics: Adamantane; Antiviral Agents; Biological Assay; Enzyme Inhibitors; Humans; Influenza, Human; Models, Biological; Neuraminidase; Treatment Outcome	2015
An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses. Antiviral research, 2017, Volume: 140 Topics: Adamantane; Amantadine; Animals; Antiviral Agents; Dogs; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Inhibitory Concentration 50; Madin Darby Canine Kidney Cells; Molecular Dynamics Simulation; Mutation; Orthomyxoviridae Infections; Spiro Compounds; Structure-Activity Relationship; Viral Matrix Proteins	2017
Adamantane resistance in influenza A(H1) viruses increased in 2007 in South East Asia but decreased in Australia and some other countries. Antiviral research, 2008, Volume: 80, Issue:2 Topics: Adamantane; Animals; Antiviral Agents; Asia, Southeastern; Australia; Cell Line; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza A virus; Influenza, Human; Neuraminidase; Phylogeny; Viral Proteins	2008
Control of an outbreak due to an adamantane-resistant strain of influenza A (H3N2) in a chronic care facility. Infection, 2008, Volume: 36, Issue:5 Topics: Adamantane; Adolescent; Adult; Child; Child, Preschool; Disease Outbreaks; Drug Resistance, Viral; Female; Humans; Infection Control; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Mutation; Nursing Homes; Retrospective Studies; Young Adult	2008
Evolution of drug resistance in multiple distinct lineages of H5N1 avian influenza. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2009, Volume: 9, Issue:2 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Evolution, Molecular; Genome, Viral; Genotype; Humans; Influenza A Virus, H5N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; Reassortant Viruses; Selection, Genetic; Viral Matrix Proteins	2009
Human influenza A viruses isolated in South America: genetic relations, adamantane resistance and vaccine strain match. Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2009, Volume: 9, Issue:2 Topics: Adamantane; Amino Acid Sequence; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Molecular Epidemiology; Molecular Sequence Data; Phylogeny; Uruguay	2009
Influenza antiviral resistance testing in new york and wisconsin, 2006 to 2008: methodology and surveillance data. Journal of clinical microbiology, 2009, Volume: 47, Issue:5 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; New York; RNA, Viral; Sequence Analysis, DNA; Viral Proteins; Wisconsin	2009
Influenza virus resistance to antiviral agents: a plea for rational use. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2009, May-01, Volume: 48, Issue:9 Topics: Adamantane; Animals; Antiviral Agents; Drug Resistance, Viral; Drug Therapy, Combination; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza A Virus, H5N1 Subtype; Influenza B virus; Influenza, Human; Oseltamivir	2009
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses. Virology, 2009, Jun-05, Volume: 388, Issue:2 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Phylogeny; Sequence Analysis, DNA; Viral Matrix Proteins	2009
Perspectives on influenza virus infection. Pediatrics and neonatology, 2009, Volume: 50, Issue:2 Topics: Adamantane; Adolescent; Humans; Influenza A virus; Influenza B virus; Influenza, Human; Neuraminidase	2009
Rapid spread of drug-resistant influenza A viruses in the Basque Country, northern Spain, 2000-1 to 2008-9. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2009, May-21, Volume: 14, Issue:20 Topics: Adamantane; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation; Oseltamivir; Spain	2009
Susceptibility of antiviral drugs against 2009 influenza A (H1N1) virus. Biochemical and biophysical research communications, 2009, Jul-31, Volume: 385, Issue:3 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Viral Matrix Proteins	2009
Antiviral resistance in influenza viruses circulating in Central and South America based on the detection of established genetic markers. Influenza and other respiratory viruses, 2009, Volume: 3, Issue:2 Topics: Adamantane; Amino Acid Sequence; Animals; Antiviral Agents; Cell Line; Central America; Dogs; Drug Resistance, Viral; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Male; Molecular Sequence Data; Neuraminidase; Orthomyxoviridae; Oseltamivir; Sequence Alignment; South America; Viral Matrix Proteins	2009
Extrapolating from sequence--the 2009 H1N1 'swine' influenza virus. Nature biotechnology, 2009, Volume: 27, Issue:6 Topics: Adamantane; Amino Acid Sequence; Amino Acid Substitution; Antiviral Agents; Consensus Sequence; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Polysaccharides; Protein Binding; RNA-Dependent RNA Polymerase; Sequence Analysis, Protein; Viral Matrix Proteins; Viral Proteins	2009
Dynamics of antiviral-resistant influenza viruses in the Netherlands, 2005-2008. Antiviral research, 2009, Volume: 83, Issue:3 Topics: Adamantane; Antiviral Agents; Cluster Analysis; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Netherlands; Phylogeny; RNA, Viral; Sequence Analysis, DNA; Sequence Homology, Amino Acid	2009
Genomic events underlying the changes in adamantane resistance among influenza A(H3N2) viruses during 2006-2008. Influenza and other respiratory viruses, 2009, Volume: 3, Issue:6 Topics: Adamantane; Antiviral Agents; Cluster Analysis; Drug Resistance, Viral; Genome, Viral; Genotype; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Phylogeny; RNA, Viral; Sequence Analysis, DNA; Sequence Homology	2009
Safety of oseltamivir compared with the adamantanes in children less than 12 months of age. The Pediatric infectious disease journal, 2010, Volume: 29, Issue:3 Topics: Adamantane; Antiviral Agents; Central Nervous System; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Nervous System Diseases; Oseltamivir; Retrospective Studies; Rimantadine	2010
Antiviral prescriptions to U.S. ambulatory care visits with a diagnosis of influenza before and after high level of adamantane resistance 2005-06 season. PloS one, 2010, Jan-28, Volume: 5, Issue:1 Topics: Adamantane; Adolescent; Adult; Ambulatory Care; Antiviral Agents; Child; Child, Preschool; Cross-Sectional Studies; Female; Humans; Infant; Infant, Newborn; Influenza, Human; Male; Middle Aged; Seasons; United States; Young Adult	2010
Double (V27A/S31N) mutant 2009 pandemic influenza A (H1N1) virus isolated from adamantane non-treated inmunocompetent child. Diagnostic microbiology and infectious disease, 2010, Volume: 67, Issue:1 Topics: Adamantane; Adolescent; Amino Acid Substitution; Antiviral Agents; Female; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation, Missense; Spain; Viral Matrix Proteins	2010
Influenza antiviral prescribing practices during the 2007-08 and 2008-09 influenza seasons in the setting of increased resistance to oseltamivir among circulating influenza viruses. Antiviral research, 2010, Volume: 88, Issue:2 Topics: Adamantane; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Drug Utilization; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Oseltamivir; Practice Guidelines as Topic; Practice Patterns, Physicians'; Retrospective Studies; Rimantadine; Seasons; Surveys and Questionnaires; Zanamivir	2010
Influence of an additional amino group on the potency of aminoadamantanes against influenza virus A. II - Synthesis of spiropiperazines and in vitro activity against influenza A H3N2 virus. Bioorganic chemistry, 2010, Volume: 38, Issue:6 Topics: Adamantane; Animals; Antiviral Agents; Cell Line; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Orthomyxoviridae Infections; Piperazines; Spiro Compounds	2010
Emerging influenza antiviral resistance threats. The Journal of infectious diseases, 2011, Jan-01, Volume: 203, Issue:1 Topics: Adamantane; Antiviral Agents; Drug Resistance, Multiple, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation, Missense; Oseltamivir; Reassortant Viruses; Virus Replication	2011
Dual resistance to adamantanes and oseltamivir among seasonal influenza A(H1N1) viruses: 2008-2010. The Journal of infectious diseases, 2011, Jan-01, Volume: 203, Issue:1 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Drug Resistance, Multiple, Viral; Genome, Viral; Genotype; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation, Missense; Neuraminidase; Oseltamivir; RNA, Viral; Viral Matrix Proteins; Viral Proteins	2011
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro. Antiviral therapy, 2010, Volume: 15, Issue:8 Topics: Acids, Carbocyclic; Adamantane; Amino Acid Substitution; Animals; Antiviral Agents; Cell Line; Cyclopentanes; Dogs; Drug Resistance, Viral; Enzyme Inhibitors; Guanidines; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Mutation, Missense; Neuraminidase; Oseltamivir; Pyrans; Pyrrolidines; Sialic Acids; Viral Plaque Assay; Zanamivir	2010
Antiviral drugs for influenza. The Medical letter on drugs and therapeutics, 2011, Jan-10, Volume: 53, Issue:1355 Topics: Adamantane; Antiviral Agents; Disease Outbreaks; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Influenza, Human; Neuraminidase	2011
Oseltamivir-resistant pandemic (H1N1) 2009 virus, Mexico. Emerging infectious diseases, 2011, Volume: 17, Issue:2 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Female; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mexico; Microbial Sensitivity Tests; Neuraminidase; Oseltamivir; Pandemics; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Zanamivir	2011
Adamantane- and oseltamivir-resistant seasonal A (H1N1) and pandemic A (H1N1) 2009 influenza viruses in Guangdong, China, during 2008 and 2009. Journal of clinical microbiology, 2011, Volume: 49, Issue:7 Topics: Adamantane; China; Cluster Analysis; Drug Resistance, Viral; Genotype; Humans; Influenza A Virus, H1N1 Subtype; Influenza, Human; Microbial Sensitivity Tests; Molecular Sequence Data; Neuraminidase; Oseltamivir; Sequence Analysis, DNA; Viral Matrix Proteins; Viral Proteins	2011
[Influenza : clinical symptoms, diagnostics and therapy]. Der Internist, 2011, Volume: 52, Issue:9 Topics: Adamantane; Adult; Age Factors; Aged; AIDS-Related Opportunistic Infections; Antiviral Agents; Child; Child, Preschool; Female; Germany; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza Vaccines; Influenza, Human; Male; Neuraminidase; Pandemics; Pneumonia, Viral; Population Surveillance; Pregnancy; Rimantadine; Survival Rate	2011
H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS pathogens, 2012, Volume: 8, Issue:9 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Binding Sites; Crystallography, X-Ray; Drug Resistance, Viral; Enzyme Inhibitors; Humans; Hydrophobic and Hydrophilic Interactions; Influenza A Virus, H1N1 Subtype; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Pandemics; Protein Conformation; Zanamivir	2012
Spiro[pyrrolidine-2,2'-adamantanes]: synthesis, anti-influenza virus activity and conformational properties. Bioorganic & medicinal chemistry letters, 2003, May-19, Volume: 13, Issue:10 Topics: Adamantane; Antiviral Agents; Cell Line; Humans; Influenza A virus; Influenza, Human; Models, Molecular; Molecular Conformation; Nuclear Magnetic Resonance, Biomolecular; Pyrrolidines; Structure-Activity Relationship	2003
[Treatment of influenza in children]. Zhonghua er ke za zhi = Chinese journal of pediatrics, 2003, Volume: 41, Issue:2 Topics: Adamantane; Amantadine; Antiviral Agents; Child; Guanidines; Humans; Influenza, Human; Pyrans; Rimantadine; Sialic Acids; Zanamivir	2003
Resistance to anti-influenza agents. Lancet (London, England), 2005, Oct-01, Volume: 366, Issue:9492 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza Vaccines; Influenza, Human	2005
High levels of adamantane resistance among influenza A (H3N2) viruses and interim guidelines for use of antiviral agents--United States, 2005-06 influenza season. MMWR. Morbidity and mortality weekly report, 2006, Jan-20, Volume: 55, Issue:2 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Practice Guidelines as Topic; Seasons; United States	2006
Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States. JAMA, 2006, Feb-22, Volume: 295, Issue:8 Topics: Adamantane; Antiviral Agents; Biological Assay; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation; Seasons; Sequence Analysis; United States; Viral Matrix Proteins	2006
Adamantane resistance in influenza A. JAMA, 2006, Feb-22, Volume: 295, Issue:8 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Viral Matrix Proteins	2006
Influenza-associated deaths among children. The New England journal of medicine, 2006, Mar-23, Volume: 354, Issue:12 Topics: Acetamides; Adamantane; Antiviral Agents; Child; Humans; Influenza, Human; Oseltamivir; United States	2006
Increased adamantane resistance in influenza A(H3) viruses in Australia and neighbouring countries in 2005. Antiviral research, 2007, Volume: 73, Issue:2 Topics: Adamantane; Antiviral Agents; Australia; Drug Resistance, Viral; Hemagglutinin Glycoproteins, Influenza Virus; Humans; Influenza A virus; Influenza, Human; Mutation; Neuraminidase; Oseltamivir; Phylogeny; Rimantadine; Zanamivir	2007
Shift shown in influenza A adamantane resistance. JAMA, 2006, Oct-04, Volume: 296, Issue:13 Topics: Adamantane; Alzheimer Disease; Antiviral Agents; Drug Resistance, Viral; Excitatory Amino Acid Antagonists; Humans; Influenza A virus; Influenza, Human; Memantine	2006
Shift shown in influenza A adamantane resistance. JAMA, 2006, Oct-04, Volume: 296, Issue:13 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Neuraminidase	2006
Drug resistance among influenza A viruses isolated in Italy from 2000 to 2005: are the emergence of Adamantane-resistant viruses cause of concern? Journal of preventive medicine and hygiene, 2006, Volume: 47, Issue:1 Topics: Adamantane; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A virus; Influenza, Human; Italy; Neuraminidase	2006
The emergence of adamantane resistance in influenza A(H1) viruses in Australia and regionally in 2006. Antiviral research, 2007, Volume: 75, Issue:2 Topics: Adamantane; Adolescent; Adult; Aged; Amino Acid Substitution; Antiviral Agents; Asia, Eastern; Asia, Southeastern; Australia; Child; Child, Preschool; Drug Resistance, Viral; Genotype; Humans; Infant; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Middle Aged; Pacific Islands; Prevalence; Rimantadine; South Africa	2007
The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Molecular biology and evolution, 2007, Volume: 24, Issue:8 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Asia; Australia; Biological Assay; Drug Resistance, Viral; Evolution, Molecular; Genetic Variation; Genome, Viral; Humans; Influenza A Virus, H3N2 Subtype; Influenza, Human; Japan; New Zealand; Phylogeny; United States; Viral Matrix Proteins	2007
Pandemic flu vaccine: are we doing enough? Clinical pharmacology and therapeutics, 2007, Volume: 82, Issue:6 Topics: Adamantane; Adjuvants, Immunologic; Animals; Antiviral Agents; Disease Outbreaks; Drug Approval; Drug Design; Drug Resistance, Viral; Enzyme Inhibitors; History, 20th Century; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H5N1 Subtype; Influenza in Birds; Influenza Vaccines; Influenza, Human; Neuraminidase; Oseltamivir; Poultry; United States; United States Food and Drug Administration	2007
Adamantane-resistant influenza infection during the 2004-05 season. Emerging infectious diseases, 2008, Volume: 14, Issue:1 Topics: Adamantane; Adolescent; Adult; Aged; Antiviral Agents; Child; Child, Preschool; Cohort Studies; Disease Outbreaks; Drug Resistance, Viral; Female; Humans; Infant; Influenza A Virus, H3N2 Subtype; Influenza B virus; Influenza, Human; Male; Middle Aged; Wisconsin	2008
Adamantane resistance in circulating human influenza A viruses from Alberta, Canada (1970-2007). Antiviral research, 2008, Volume: 79, Issue:2 Topics: Adamantane; Alberta; Antiviral Agents; Drug Resistance, Viral; Humans; Influenza A Virus, H1N1 Subtype; Influenza A Virus, H3N2 Subtype; Influenza, Human; Mutation, Missense; Time Factors; Viral Matrix Proteins	2008
Emergence of adamantane-resistant influenza A(H3N2) viruses in Hong Kong between 1997 and 2006. Journal of medical virology, 2008, Volume: 80, Issue:5 Topics: Adamantane; Amino Acid Substitution; Antiviral Agents; Child; Child, Preschool; Drug Resistance, Viral; Drug Utilization Review; Hong Kong; Humans; Infant; Influenza A Virus, H3N2 Subtype; Influenza, Human; Molecular Sequence Data; Mutation, Missense; RNA, Viral; Sequence Analysis, DNA; Viral Matrix Proteins	2008
[Combined prevention of influenza using inactivated influenza vaccine and remantadine in organized collectives of adults]. Trudy Instituta imeni Pastera, 1982, Volume: 57 Topics: Adamantane; Adult; Disease Outbreaks; Drug Evaluation; Humans; Influenza Vaccines; Influenza, Human; Rimantadine; Russia; Vaccines, Attenuated	1982
[Organization and evaluation of the effectiveness of emergency prophylaxis and early treatment of influenza with remantadine in Serevodvinsk]. Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1983, Issue:3 Topics: Adamantane; Adult; Drug Evaluation; Emergencies; Epidemiologic Methods; Humans; Influenza, Human; Rimantadine; Russia; Time Factors; Urban Population	1983
[Efficacy of remantadin in influenza B]. Terapevticheskii arkhiv, 1983, Volume: 55, Issue:9 Topics: Adamantane; Adult; Humans; Influenza, Human; Orthomyxoviridae; Rimantadine; Russia; Serotyping	1983
[Effectiveness of remantadine in outpatients during a period of epidemic outbreaks of influenza A and B]. Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1984, Issue:1 Topics: Absenteeism; Adamantane; Ambulatory Care; Disease Outbreaks; Drug Evaluation; Humans; Influenza, Human; Rimantadine; Russia; Urban Population	1984
[New organized approach to rendering medical services to patients during influenza outbreak]. Terapevticheskii arkhiv, 1984, Volume: 56, Issue:1 Topics: Adamantane; Antiviral Agents; Disease Outbreaks; Humans; Influenza A virus; Influenza, Human; Rimantadine; Russia	1984
[Emergency prevention of influenza with remantadine]. Meditsinskaia sestra, 1984, Volume: 43, Issue:3 Topics: Adamantane; Adolescent; Adult; Disease Outbreaks; Humans; Influenza, Human; Rimantadine; USSR	1984
[Amantadine and riamantadine in the treatment of influenza]. Recenti progressi in medicina, 1983, Volume: 74, Issue:3 Topics: Adamantane; Amantadine; Humans; Influenza, Human; Rimantadine	1983
[Emergency prevention of influenza with remantadin]. Zhurnal mikrobiologii, epidemiologii i immunobiologii, 1982, Issue:9 Topics: Adamantane; Adolescent; Adult; Disease Outbreaks; Drug Evaluation; Female; Humans; Influenza Vaccines; Influenza, Human; Male; Placebos; Rimantadine; USSR	1982
[Therapeutic effectiveness of rimantadine and antigrippen against A1(H1N1) influenza in the 1977-1978 epidemic]. Vrachebnoe delo, 1981, Issue:6 Topics: Adamantane; Adult; Ascorbic Acid; Aspirin; Diphenhydramine; Drug Combinations; Evaluation Studies as Topic; Humans; Influenza, Human; Lactates; Rimantadine; Rutin; USSR	1981
[Experience with clinical trials of the new anti-influenza drug rimantadine]. Vrachebnoe delo, 1981, Issue:4 Topics: Adamantane; Antiviral Agents; Ascorbic Acid; Aspirin; Diphenhydramine; Drug Combinations; Humans; Influenza, Human; Lactates; Retrospective Studies; Rimantadine; Rutin	1981
[Clinical use of the anti-influenza preparation rimantadine]. Klinicheskaia meditsina, 1981, Volume: 59, Issue:2 Topics: Adamantane; Humans; Influenza A virus; Influenza, Human; Rimantadine	1981
Comparison of amantadine and rimantadine for prevention of type A (Russian) influenza. Antiviral research, 1981, Volume: 1, Issue:3 Topics: Adamantane; Adolescent; Adult; Age Factors; Amantadine; Antibodies, Viral; Double-Blind Method; Drug Evaluation; Female; Humans; Influenza A virus; Influenza, Human; Male; Rimantadine	1981
[Prevention of pneumonia in influenza A by means of a new anti-influenza drug rimantadine]. Terapevticheskii arkhiv, 1980, Volume: 52, Issue:3 Topics: Adamantane; Adult; Humans; Influenza A virus; Influenza, Human; Middle Aged; Pneumonia, Viral	1980
[Treatment of patients with influenza]. Terapevticheskii arkhiv, 1975, Volume: 47, Issue:8 Topics: Adamantane; Adolescent; Adult; Aged; Codeine; Critical Care; Dipyrone; Drug Evaluation; Ephedrine; gamma-Globulins; Gossypol; Humans; Imidazoles; Influenza, Human; Interferons; Lactoglobulins; Middle Aged; Naphthoquinones; Oxygen Inhalation Therapy; Sympathomimetics; Time Factors	1975
[Chemotherapy of virus diseases]. MMW, Munchener medizinische Wochenschrift, 1978, Jun-02, Volume: 120, Issue:22 Topics: Adamantane; Cytarabine; Humans; Idoxuridine; Influenza, Human; Interferons; Vidarabine; Virus Diseases	1978
Rimantadine and seizures. Annals of internal medicine, 1989, Feb-15, Volume: 110, Issue:4 Topics: Adamantane; Adult; Aged; Aged, 80 and over; Anticonvulsants; Humans; Influenza, Human; Male; Rimantadine; Seizures	1989
Resistance of influenza A virus to amantadine and rimantadine: results of one decade of surveillance. The Journal of infectious diseases, 1989, Volume: 159, Issue:3 Topics: Adamantane; Amantadine; Animals; Antigens, Viral; Cell Line; Cytopathogenic Effect, Viral; Dogs; Drug Resistance; Enzyme-Linked Immunosorbent Assay; Humans; Influenza A virus; Influenza, Human; Rimantadine; Viral Plaque Assay	1989
[Principles of the use of anti-influenza drugs]. Terapevticheskii arkhiv, 1988, Volume: 60, Issue:8 Topics: Adamantane; Ambulatory Care; Disease Outbreaks; Drug Administration Schedule; Humans; Influenza, Human; Rimantadine; Russia	1988
Current status of amantadine and rimantadine as anti-influenza-A agents: memorandum from a WHO meeting. Bulletin of the World Health Organization, 1985, Volume: 63, Issue:1 Topics: Adamantane; Amantadine; Humans; Influenza A virus; Influenza, Human; Rimantadine	1985